Literature DB >> 10198219

Biochemical localisation of the 5-HT2A (serotonin) receptor in rat skeletal muscle.

E Hajduch1, L Dombrowski, F Darakhshan, F Rencurel, A Marette, H S Hundal.   

Abstract

The 5-HT2A receptor was recently shown to localise morphologically to the transverse tubules (TT) in rat foetal myoblasts. Receptor activation enhanced the expression of genes involved in myogenesis, and its TT localisation has led to the suggestion that it may participate in excitation-contraction coupling. In order to gain further insights into 5-HT2A receptor function in muscle we have (i) investigated its biochemical localisation in adult rat skeletal muscle and (ii) determined whether receptor expression is dependent upon muscle type. Immunoblot analysis of muscle membranes, isolated by subcellular fractionation, revealed that adult muscle expresses the 5-HT2A receptor and that it resides exclusively in plasma membranes and not in TT. No differences in 5-HT2A abundance were observed between red and white muscle, suggesting that receptor expression does not correlate with the metabolic or contractile properties of the muscle fibre. Our data indicate that 5-HT2A expression in skeletal muscle is maintained into adulthood and that its absence from TT make it an unlikely participant in the excitation-contraction coupling process. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198219     DOI: 10.1006/bbrc.1999.0471

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message?

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2000-06       Impact factor: 4.530

2.  Blocking of striated muscle degeneration by serotonin in C. elegans.

Authors:  Maité Carre-Pierrat; Marie-Christine Mariol; Lucie Chambonnier; Aurélie Laugraud; Fabienne Heskia; Jean Giacomotto; Laurent Ségalat
Journal:  J Muscle Res Cell Motil       Date:  2006-06-22       Impact factor: 2.698

3.  Serotonin regulates 6-phosphofructo-1-kinase activity in a PLC-PKC-CaMK II- and Janus kinase-dependent signaling pathway.

Authors:  Wagner Santos Coelho; Mauro Sola-Penna
Journal:  Mol Cell Biochem       Date:  2012-09-26       Impact factor: 3.396

4.  Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Trent A Waugh; Eric Horstick; Junguk Hur; Samuel W Jackson; Ann E Davidson; Xingli Li; James J Dowling
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

5.  Effect of serotonin modulation on dystrophin-deficient zebrafish.

Authors:  Janelle M Spinazzola; Matthias R Lambert; Devin E Gibbs; James R Conner; Georgia L Krikorian; Prithu Pareek; Carlo Rago; Louis M Kunkel
Journal:  Biol Open       Date:  2020-08-28       Impact factor: 2.422

Review 6.  The serotonergic system dysfunction in diabetes mellitus.

Authors:  Yan Cai; Xiaolong Li; Hongli Zhou; Jiyin Zhou
Journal:  Front Cell Neurosci       Date:  2022-07-14       Impact factor: 6.147

7.  Serotonin and Histamine Therapy Increases Tetanic Forces of Myoblasts, Reduces Muscle Injury, and Improves Grip Strength Performance of Dmd(mdx) Mice.

Authors:  Volkan Gurel; Jeremy Lins; Kristyn Lambert; Joan Lazauski; James Spaulding; John McMichael
Journal:  Dose Response       Date:  2015-11-11       Impact factor: 2.658

8.  The psychoactive drug 25B-NBOMe recapitulates rhabdomyolysis in zebrafish larvae.

Authors:  Genri Kawahara; Hideyuki Maeda; Ruri Kikura-Hanajiri; Ken-Ichi Yoshida; Yukiko K Hayashi
Journal:  Forensic Toxicol       Date:  2017-04-18       Impact factor: 4.096

9.  Serotonin hormonally regulates lacrimal gland secretory function via the serotonin type 3a receptor.

Authors:  Toshihiro Imada; Shigeru Nakamura; Ryuji Hisamura; Yusuke Izuta; Kai Jin; Masataka Ito; Naoki Kitamura; Kenji F Tanaka; Masaru Mimura; Izumi Shibuya; Kazuo Tsubota
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.